Related Experiment Video
Updated: Jun 28, 2025

Transcriptome-Wide Profiling of Protein-RNA Interactions by Cross-Linking and Immunoprecipitation Mediated by FLAG-Biotin Tandem Purification
Published on: May 18, 2020
Regulating Protein-RNA Interactions: Advances in Targeting the LIN28/Let-7 Pathway
Greater Kayode Oyejobi1, Xiaodan Yan1, Piotr Sliz2
1Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.
Abstract:
Originally discovered in C. elegans, LIN28 is an evolutionarily conserved zinc finger RNA-binding protein (RBP) that post-transcriptionally regulates genes involved in developmental timing, stem cell programming, and oncogenesis. LIN28 acts via two distinct mechanisms. It blocks the biogenesis of the lethal-7 (let-7) microRNA (miRNA) family, and also directly binds messenger RNA (mRNA) targets, such as IGF-2 mRNA, and alters downstream splicing and translation events. This review focuses on the molecular mechanism of LIN28 repression of let-7 and current strategies to overcome this blockade for the purpose of cancer therapy. We highlight the value of the LIN28/let-7 pathway as a drug target, as multiple oncogenic proteins that the pathway regulates are considered undruggable due to their inaccessible cellular location and lack of cavities for small molecule binding.
Insights
LIN28 protein blocks microRNA production, impacting development and cancer. Overcoming this LIN28/let-7 pathway blockade offers new cancer therapy strategies, targeting previously undruggable proteins.
Area of Science:
- Molecular Biology
- Developmental Biology
- Oncology
Background:
- LIN28 is a conserved RNA-binding protein regulating development and oncogenesis.
- LIN28 inhibits the let-7 microRNA family and directly targets mRNAs like IGF-2.
- The LIN28/let-7 pathway is crucial in stem cell programming and cancer progression.
Purpose of the Study:
- To review the molecular mechanisms of LIN28-mediated let-7 repression.
- To discuss current strategies for overcoming LIN28/let-7 blockade in cancer therapy.
- To highlight the LIN28/let-7 pathway as a promising drug target.
Main Methods:
- Literature review of LIN28 function and regulatory mechanisms.
- Analysis of LIN28's role in microRNA biogenesis and mRNA processing.
- Exploration of therapeutic strategies targeting the LIN28/let-7 pathway.
Main Results:
- LIN28 represses let-7 biogenesis and affects mRNA splicing and translation.
- The LIN28/let-7 pathway regulates key oncogenic proteins.
- Targeting this pathway may overcome resistance to conventional cancer therapies.
Conclusions:
- Understanding LIN28's molecular mechanisms is key to developing novel cancer treatments.
- The LIN28/let-7 pathway presents a viable target for therapeutic intervention.
- Strategies to overcome LIN28-mediated repression could unlock treatments for cancers with undruggable targets.
Related Concept Videos
MicroRNAs
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

